Viropro, Inc. to Unlock Value from its Biosimilars Portfolio Genetic Engineering News (press release) It is from this portfolio that Viropro signed a Letter of Agreement with Spectrum Pharmaceuticals, Inc. for Rituximab, and is in active discussions with potential clients for its other biosimilar technologies. (“®” are registered trademarks of their ... |
